<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04585165</url>
  </required_header>
  <id_info>
    <org_study_id>Napneung-2</org_study_id>
    <nct_id>NCT04585165</nct_id>
  </id_info>
  <brief_title>User-friendly HIV Testing and Counseling Services</brief_title>
  <official_title>Cohort of Individuals at Risk of HIV Infection Recruited in User-friendly HIV Testing and Counseling Services in Thailand Provinces</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut de Recherche pour le Developpement</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Expertise France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Chiang Mai University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut de Recherche pour le Developpement</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Multicenter cohort study of individuals reporting behavioral risks of HIV acquisition,&#xD;
      recruited among those presenting for testing for HIV and other sexually transmitted&#xD;
      infections.&#xD;
&#xD;
      Overarching goal: to study factors associated with uptake of HIV prevention and (re)testing&#xD;
      services in medium-sized cities in Thailand.&#xD;
&#xD;
      Primary objective: To estimate the incidence of HIV and other sexually transmitted infections&#xD;
      (syphilis, chronic hepatitis B and C) among individuals presenting for retesting.&#xD;
&#xD;
      Secondary objectives:&#xD;
&#xD;
        -  To evaluate the uptake of pre-exposure prophylaxis&#xD;
&#xD;
        -  To assess retention in the study&#xD;
&#xD;
        -  To evaluate client HIV knowledge&#xD;
&#xD;
        -  To describe HIV prevalence and characteristics of individuals newly diagnosed with HIV&#xD;
&#xD;
        -  To describe characteristics of individuals at risk of HIV infection&#xD;
&#xD;
        -  To assess the quality of the testing and referral services.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Testing and counseling for HIV, syphilis and other sexually transmitted infections is&#xD;
      provided to consenting individuals.&#xD;
&#xD;
      Components: interactive counseling program, self sampling (finger prick) under supervision,&#xD;
      questionnaire (on a tablet computer) to assess risks of HIV acquisition, understanding of HIV&#xD;
      transmission routes and pre-exposure prophylaxis, willingness to take pre-exposure&#xD;
      prophylaxis if at risk of HIV, and satisfaction with regard to services provided.&#xD;
&#xD;
      Referral to appropriate care facility of participants diagnosed with infection. HIV negative&#xD;
      participants with significant risk of HIV are advised to come back for HIV retesting within 3&#xD;
      to 6 months and informed about pre-exposure prophylaxis.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 19, 2020</start_date>
  <completion_date type="Anticipated">December 2024</completion_date>
  <primary_completion_date type="Anticipated">September 2024</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>HIV incidence</measure>
    <time_frame>Through study completion, an average of 3 years</time_frame>
    <description>HIV incidence</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Participants initiating pre-exposure prophylaxis</measure>
    <time_frame>Through study completion, an average of 3 years</time_frame>
    <description>Proportion of participants initiating pre-exposure prophylaxis among those at significant risk of HIV</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Retention</measure>
    <time_frame>Through study completion, an average of 3 years</time_frame>
    <description>Cumulative probability of retest</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>HIV knowledge</measure>
    <time_frame>Through study completion, an average of 3 years</time_frame>
    <description>Answers to a self-constructed questionnaire assessing participants' knowledge of HIV transmission routes and pre-exposure prophylaxis, following counseling. The questionnaire is composed of one multiple-choice question on HIV transmission routes and three True/False questions on pre-exposure prophylaxis. The results will be reported item by item. Exploratory data analyses may be conducted using, for example, principal component analysis.</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">3000</enrollment>
  <condition>HIV Infections</condition>
  <condition>Sexually Transmitted Infection</condition>
  <condition>Hepatitis B, Chronic</condition>
  <condition>Hepatitis C</condition>
  <arm_group>
    <arm_group_label>Risk of HIV acquisition</arm_group_label>
    <description>Individuals reporting behavioral risk of HIV acquisition.</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma from remaining blood sample&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Individuals requesting a test for HIV and sexually transmitted infections&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Aged 15 years or more&#xD;
&#xD;
          -  Willing to be tested for HIV and other sexually transmitted infections&#xD;
&#xD;
          -  Able to understand the study and its procedures&#xD;
&#xD;
        Exclusion Criteria: None&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gonzague Jourdain, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut de recherche pour le d√©veloppement, and Chiang Mai University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gonzague Jourdain, MD, PhD</last_name>
    <phone>+66 5324 0910</phone>
    <email>Gonzague.Jourdain@ird.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nicolas Salvadori, PhD</last_name>
    <phone>+66 5324 0910</phone>
    <email>Nicolas.Salvadori@phpt.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>STIs Clinic of the Office of Disease Prevention and Control Region 1</name>
      <address>
        <city>Chiang Mai</city>
        <zip>50100</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chonlatorn Boontan, MD</last_name>
      <phone>+66 53 276364</phone>
      <email>firstboontan@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Clinical Service Center, Faculty of Associated Medical Sciences, Chiang Mai University</name>
      <address>
        <city>Chiang Mai</city>
        <zip>50200</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Phennapha Klangsinsirikul, PhD</last_name>
      <phone>+66 53 949220</phone>
      <email>phennapha.k@cmu.ac.th</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>MAP Foundation</name>
      <address>
        <city>Chiang Mai</city>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Brahm Press</last_name>
      <email>brahm.press@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Chiang Rai Obstetrics Clinic</name>
      <address>
        <city>Chiang Rai</city>
        <zip>57000</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jullapong Achalapong, MD</last_name>
      <phone>66 53 711 300</phone>
      <email>jullapongachalapong@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Phayao Hospital</name>
      <address>
        <city>Phayao</city>
        <zip>56000</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Guttiga Halue, MD</last_name>
      <phone>+66 54 431 209</phone>
      <email>drgutti@gmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>University of Phayao Medical Center and Hospital</name>
      <address>
        <city>Phayao</city>
        <zip>56000</zip>
        <country>Thailand</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Sawitree Nangola, PhD</last_name>
      <phone>+66 54 466 666</phone>
      <email>sawitree.na@up.ac.th</email>
    </contact>
  </location>
  <location_countries>
    <country>Thailand</country>
  </location_countries>
  <link>
    <url>https://www.napneung.net/</url>
    <description>Presentation for potential participants</description>
  </link>
  <reference>
    <citation>Salvadori N, Decker L, Ngo-Giang-Huong N, Mary JY, Chevret S, Arunothong S, Adam P, Khamduang W, Samleerat T, Luangsook P, Suksa-Ardphasu V, Achalapong J, Rouzioux C, Sirirungsi W, Jourdain G. Impact of Counseling Methods on HIV Retesting Uptake in At-Risk Individuals: A Randomized Controlled Study. AIDS Behav. 2020 May;24(5):1505-1516. doi: 10.1007/s10461-019-02695-2.</citation>
    <PMID>31605294</PMID>
  </reference>
  <reference>
    <citation>Salvadori N, Adam P, Mary JY, Decker L, Sabin L, Chevret S, Arunothong S, Khamduang W, Luangsook P, Suksa-Ardphasu V, Achalapong J, Rouzioux C, Sirirungsi W, Ngo-Giang-Huong N, Jourdain G. Appointment reminders to increase uptake of HIV retesting by at-risk individuals: a randomized controlled study in Thailand. J Int AIDS Soc. 2020 Apr;23(4):e25478. doi: 10.1002/jia2.25478.</citation>
    <PMID>32294318</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 27, 2020</study_first_submitted>
  <study_first_submitted_qc>October 12, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 14, 2020</study_first_posted>
  <last_update_submitted>February 12, 2021</last_update_submitted>
  <last_update_submitted_qc>February 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 16, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Institut de Recherche pour le Developpement</investigator_affiliation>
    <investigator_full_name>GONZAGUE JOURDAIN</investigator_full_name>
    <investigator_title>PHPT Research Team</investigator_title>
  </responsible_party>
  <keyword>HIV</keyword>
  <keyword>Testing</keyword>
  <keyword>Self-testing</keyword>
  <keyword>Retesting</keyword>
  <keyword>Early diagnosis</keyword>
  <keyword>Counseling</keyword>
  <keyword>Computer</keyword>
  <keyword>Reminder</keyword>
  <keyword>Short message service</keyword>
  <keyword>Pre-exposure prophylaxis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infections</mesh_term>
    <mesh_term>Communicable Diseases</mesh_term>
    <mesh_term>Hepatitis A</mesh_term>
    <mesh_term>Hepatitis C</mesh_term>
    <mesh_term>HIV Infections</mesh_term>
    <mesh_term>Acquired Immunodeficiency Syndrome</mesh_term>
    <mesh_term>Hepatitis B</mesh_term>
    <mesh_term>Sexually Transmitted Diseases</mesh_term>
    <mesh_term>Hepatitis B, Chronic</mesh_term>
    <mesh_term>Hepatitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

